Norethindrone Acetate And Ethinyl Estradiol Tablet
Product Images NDC 50090-6782

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Norethindrone Acetate And Ethinyl Estradiol (NDC 50090-6782). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister1 (Blister1)

A medication schedule chart for Norethindrone Acetate and Ethinyl Estradiol Tablets, USP 1 mg/0.02 mg. The diagram displays three rows labeled Week 1, Week 2, and Week 3 with circles under each day of the week from Sunday to Saturday and arrows indicating the order for taking the tablets.*

FDA Label Image

Blister2 (Blister2)

Instructional diagram for Norethindrone Acetate and Ethinyl Estradiol Tablets USP 1 mg/0.02 mg showing a weekly dosing schedule. It includes three rows labeled Week 1, Week 2, and Week 3, each containing circles for daily tablet intake from Sunday through Saturday, with arrows indicating the sequence to follow.*

FDA Label Image

Figure1 (Figure1)

A forest plot chart comparing effect estimates of various studies on combination oral contraceptive (COC) use, showing odds ratios (OR), relative risks (RR), and hazard ratios (HR) with confidence intervals. The studies compare "Ever COC vs. Never COC Use" and "Current COC use vs. Never-Use," with effect estimates plotted on the horizontal axis ranging from -1.50 to 2.00.*

FDA Label Image

Logo (Image 02)

FDA Label Image

Structure1 (Image 03)

Chemical structure of Ethinyl Estradiol, USP, showing its molecular framework including hydroxyl groups and a distinct ethynyl side group, commonly used in oral hormonal tablets.*

FDA Label Image

Structure2 (Image 04)

Chemical structure of Norethindrone Acetate, USP, showing the steroid backbone with characteristic rings and functional groups including an acetate ester and a ketone.*

FDA Label Image

Label Image (Lbl500906782)

Label for Norethindrone Acetate and Ethinyl Estradiol tablets, 1 mg / 0.02 mg strength, oral tablets. The label indicates each tablet contains norethindrone acetate, ethinyl estradiol, and identifies the manufacturer as A-S Medication Solutions. Package contains 21 tablets stored at 68 to 77 degrees Fahrenheit in one blister.*

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Table (Table 2)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Women Years by Age, Smoking Status and Oral Contraceptive Use' showing mortality rates across age groups 15-24, 25-34, 35-44, and 45+. The chart compares four groups: ever-users non-smokers, controls non-smokers, ever-users smokers, and controls smokers. Mortality rates increase with age, with smokers who are ever-users showing the highest rates, especially in the 45+ age group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.